MX2017001433A - Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana. - Google Patents

Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana.

Info

Publication number
MX2017001433A
MX2017001433A MX2017001433A MX2017001433A MX2017001433A MX 2017001433 A MX2017001433 A MX 2017001433A MX 2017001433 A MX2017001433 A MX 2017001433A MX 2017001433 A MX2017001433 A MX 2017001433A MX 2017001433 A MX2017001433 A MX 2017001433A
Authority
MX
Mexico
Prior art keywords
human blood
bioprocessing system
protein manufacturing
microscale
microscale bioprocessing
Prior art date
Application number
MX2017001433A
Other languages
English (en)
Inventor
Rao Govind
KOSTOV Yordan
Tolosa Leah
TRAN Kevin
Pilli Manohar
TOLOSA Michael
GURRAMKONDA Chandrashekar
Original Assignee
Rao Govind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rao Govind filed Critical Rao Govind
Publication of MX2017001433A publication Critical patent/MX2017001433A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3847—Multimodal interactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00—Bioreactors or fermenters specially adapted for specific uses
    • C12M21/18—Apparatus specially designed for the use of free, immobilized or carrier-bound enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Anesthesiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proporciona un sistema de bioprocesamiento para fabricar proteína a partir de sangre humana que es compacto, integrado y adecuado para producción en demanda y suministro de proteínas terapéuticas a pacientes. La propia sangre del paciente puede ser usada como la fuente de extractos celulares para la producción de las proteínas terapéuticas.
MX2017001433A 2014-07-31 2015-07-31 Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana. MX2017001433A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462031484P 2014-07-31 2014-07-31
PCT/US2015/043314 WO2016019350A2 (en) 2014-07-31 2015-07-31 Microscale bioprocessing system and method for protein manufacturing from human blood

Publications (1)

Publication Number Publication Date
MX2017001433A true MX2017001433A (es) 2017-10-02

Family

ID=55218452

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001433A MX2017001433A (es) 2014-07-31 2015-07-31 Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana.

Country Status (7)

Country Link
US (1) US20170226467A1 (es)
EP (1) EP3186355A4 (es)
CN (1) CN107406816B (es)
BR (1) BR112017002083B1 (es)
CA (1) CA2956924C (es)
MX (1) MX2017001433A (es)
WO (1) WO2016019350A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10774304B2 (en) 2011-03-08 2020-09-15 University Of Maryland, Baltimore County System and method for production of on-demand proteins in a portable unit for point of care delivery
US9982227B2 (en) 2011-03-08 2018-05-29 University Of Maryland, Baltimore County System and method for production of on-demand proteins in a portable unit for point of care delivery
EP3093335A1 (de) * 2015-05-13 2016-11-16 Bayer Technology Services GmbH Prozessleitsystem zur regelung und steuerung einer modular aufgebauten anlage zur produktion von biopharmazeutischen und biologischen makromolekularen produkten
CA3066247A1 (en) 2017-06-07 2018-12-13 University Of Maryland, Baltimore County Factory-on-a-chip for production of biologically derived medicines/biopharmaceuticals/biologics/ biotherapeutics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156681A (en) * 1974-03-28 1979-05-29 Plasmesco Ag Process for isolating albumin from blood
US4303193A (en) * 1979-01-22 1981-12-01 Haemonetics Corporation Apparatus for separating blood into components thereof
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
US5785869A (en) * 1992-02-10 1998-07-28 Baxter International Inc. Method for creating a leukocyte rich sample from a mixed population of blood cells
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
CN101529230A (zh) * 2006-10-24 2009-09-09 皇家飞利浦电子股份有限公司 糖化血红蛋白的定量测定
CN101289493B (zh) * 2008-04-22 2010-11-10 中国人民解放军第三军医大学野战外科研究所 一种从猪血中提取高纯度血红蛋白的方法
US20110319332A1 (en) * 2010-06-23 2011-12-29 Bing Lou Wong Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US9816979B2 (en) * 2010-07-27 2017-11-14 Northwestern University Devices and methods for filtering blood plasma
WO2012122413A1 (en) * 2011-03-08 2012-09-13 University Of Maryland Baltimore County Microscale bioprocessing system and method for protein manufacturing

Also Published As

Publication number Publication date
WO2016019350A3 (en) 2016-08-18
CN107406816A (zh) 2017-11-28
WO2016019350A2 (en) 2016-02-04
EP3186355A2 (en) 2017-07-05
CN107406816B (zh) 2021-10-12
EP3186355A4 (en) 2018-03-21
BR112017002083B1 (pt) 2022-04-05
CA2956924A1 (en) 2016-02-04
US20170226467A1 (en) 2017-08-10
BR112017002083A2 (pt) 2017-12-19
CA2956924C (en) 2023-08-01

Similar Documents

Publication Publication Date Title
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
PH12016500866A1 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
HUE049237T2 (hu) Készítmények a bõr sérülései, rendellenességei és betegségei kezelési eljárásaiban történõ alkalmazásra
MY174727A (en) Stable, protracted glp-1/glucagon receptor co-agonists for medical use
EP3456815A4 (en) AQUEOUS SOLUTION THAT CAN BE ADMINISTERED TO A LIVING BODY AND METHOD FOR ITS PRODUCTION
MY184890A (en) Improved a? protofibril binding antibodies
MX370953B (es) Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunes.
EP3565607A4 (en) FUSOGENOUS LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE FOR THE PRODUCTION OF THERAPEUTIC PROTEIN AND FOR TREATMENT PURPOSES
IL239629A0 (en) History of benzylideneguanidine and therapeutic use for the treatment of diseases resulting from misfolding of proteins
MX2018008645A (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
MX2017001433A (es) Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana.
MX2015012315A (es) Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica.
SA517390475B1 (ar) نظام أكياس متعددة وطريقة لتحضير مكونات الدم
EP3326637A4 (en) USE OF MANGOSTINRINDENEXTRACT FOR THE PREPARATION OF MEDICINE FOR THE TREATMENT OF SKIN DISEASES
MX2019003751A (es) Proteina terapeutica.
MX2023007706A (es) Nanoparticulas para su uso como vacuna terapeutica.
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
MX369090B (es) Sultiame para el tratamiento de apnea del sueño.
PH12016501347A1 (en) Filters for infusion sets
UA97061U (uk) Гель "імбирол" для лікування захворювань верхніх дихальних шляхів
UA101573C2 (ru) Способ хирургического лечения больных с язвенной болезнью желудка
TW202417036A (zh) 作為治療疫苗之奈米顆粒
UA97606U (ru) Способ комплексного лечения больных рецидивирующим папилломатозом гортани
MX2016001113A (es) Proceso y composicion farmaceutica de obtencion de una capsula de telmisartan e hidroclorotiazida por via humeda.